January 27, 2022

Login to your account

Username *
Password *
Remember Me

Create an account

Fields marked with an asterisk (*) are required.
Name *
Username *
Password *
Verify password *
Email *
Verify email *
Captcha *
Reload Captcha

All Articles

yuanxin-logo-300x100

By Zeyi Yang,

Yuanxin Technology doesn’t hide its ambition. In the first line of its prospectus, the company says its mission is to be the “first choice for patients’ healthcare and medication needs in China.” But the road to winning the crowded China health tech race is a long one for this Tencent- and Sequoia-backed startup, even with a recent valuation of $4 billion, according to Chinese publication Lieyunwang. Here’s everything you need to know about Yuanxin Technology’s forthcoming IPO on the Hong Kong Stock Exchange.

WHAT DOES YUANXIN DO?

There are many ways startups can crack open the health care market in China, and Yuanxin has focused on one: prescription drugs. According to its prospectus, sales of...

data-center-300x100

By Max A. Cherney, 

Initial public offerings from semiconductor companies are so rare that when networking chip designer Credo Technology filed its prospectus with the Securities and Exchange...

an-image-of-bytedance-on-a-smartphone-1-300x169

By Zeyi Yang,

As 2022 begins, the biggest question for China IPO watchers is: Will there still be any significant IPOs this year worth anticipating?

For them, 2021 was divided into two halves...

Read Also

© 2021 Disruptive Fare @ DisruptiveFare.com a production of Crediblock.com LLC

Please publish modules in offcanvas position.